RSV in Older Adults: Why Symptoms May Last Longer Than Expected
By Gloria Lancer for Ravoke.com A closer look at an underrecognized illness For years, Respiratory syncytial virus—commonly known as RSV—has been primarily associated with infants and severely ill hospitalized patients.
By Gloria Lancer for Ravoke.com
A closer look at an underrecognized illness
For years, Respiratory syncytial virus—commonly known as RSV—has been primarily associated with infants and severely ill hospitalized patients. But new research is shifting that perspective, revealing that older adults living in the community may also face a significant and often overlooked burden from the virus.
Recent studies published in Clinical Infectious Diseases highlight how RSV affects adults aged 60 and older, particularly those who are not hospitalized but still experience prolonged and disruptive symptoms.
Tracking RSV across Europe
An international research group studied RSV cases across six countries—Finland, Germany, Italy, Poland, Spain, and the United Kingdom—over three respiratory virus seasons between 2021 and 2024.
The findings show that RSV infections among older adults ranged from relatively low levels during the height of pandemic restrictions to much higher rates once those measures eased. As social interactions resumed, RSV cases increased noticeably, reflecting a broader global trend.
Symptoms that stand out
Although RSV symptoms in older adults often resemble those of other respiratory illnesses, the studies found some key differences.
People with RSV were more likely to experience shortness of breath and a productive cough compared to those with other viral infections. At the same time, common symptoms such as congestion, fatigue, and coughing appeared at similar rates across all respiratory illnesses, making RSV difficult to diagnose without testing.
This overlap creates a challenge for healthcare providers, as RSV cannot reliably be identified based on symptoms alone.
Lingering illness and slow recovery
One of the most striking findings is how long symptoms can last. Many older adults reported ongoing issues—especially coughing—for weeks after the initial infection.
On average, symptoms persisted for about three weeks, significantly longer than many people expect from a typical respiratory illness. This prolonged recovery can interfere with daily life, limit physical activity, and contribute to overall fatigue and discomfort.
Frequent doctor visits and antibiotic use
The extended duration of illness often leads patients to seek medical care multiple times. The studies found that older adults with RSV visited their doctors more frequently, particularly those over age 80.
A large percentage of patients were also prescribed antibiotics, despite RSV being a viral infection that does not respond to these medications. In many cases, antibiotic courses lasted over two weeks, and some patients received multiple rounds of treatment.
This pattern raises concerns about unnecessary antibiotic use, which can contribute to antibiotic resistance and other health risks.
Impact on quality of life
Beyond physical symptoms, RSV appears to take a measurable toll on quality of life. Persistent coughing, breathing difficulties, and fatigue can make it harder for older adults to maintain independence and engage in everyday activities.
Even moderate cases—those not requiring hospitalization—can disrupt routines and reduce overall well-being for extended periods.
The role of vaccination
The introduction of RSV vaccines has prompted renewed attention to the virus’s impact on older populations. Experts believe vaccination could play a key role in preventing not only severe illness but also these longer-lasting, moderate cases.
Reducing the number of infections may also decrease unnecessary antibiotic use and ease the burden on healthcare systems.
Why awareness matters
Because RSV symptoms often resemble those of other respiratory illnesses, many cases may go undiagnosed or misattributed. This lack of awareness can delay appropriate care and lead to ineffective treatments.
Improving recognition of RSV in older adults—especially in outpatient settings—could help ensure better management and reduce complications.
Extending the conversation: why RSV deserves more attention
The growing focus on RSV in older adults reflects a broader shift in how respiratory illnesses are understood. Traditionally, viruses like RSV were seen as major threats primarily to infants or individuals with severe underlying conditions. However, these new findings suggest that even relatively healthy older adults may experience meaningful health impacts that extend beyond the acute phase of infection.
One key concern is how prolonged symptoms can contribute to a cycle of declining health. For older individuals, extended periods of inactivity due to fatigue or breathing difficulties can lead to muscle loss, reduced mobility, and increased vulnerability to other illnesses. This is especially important for those already managing chronic conditions such as heart or lung disease.
Another issue is the potential for misdiagnosis. Because RSV symptoms closely resemble those of other respiratory infections—including influenza and COVID-19—patients may not receive accurate diagnoses without proper testing. This can lead to repeated doctor visits, delayed recovery, and unnecessary treatments, including antibiotics that offer no benefit against viral infections.
The studies also highlight a gap in outpatient care research. While severe RSV cases in hospitals have been well documented, less is known about how the virus affects people recovering at home. This new data helps fill that gap, offering a clearer picture of the true burden of disease in the community.
Looking ahead, public health experts emphasize the importance of prevention strategies, particularly vaccination and early detection. As RSV vaccines become more widely available, they could help reduce not only hospitalizations but also the prolonged, quality-of-life impacts seen in these studies.
Ultimately, these findings serve as a reminder that respiratory viruses can have lasting effects—especially for older adults—and that even moderate illnesses deserve careful attention and appropriate care.
References
- Clinical Infectious Diseases – RSV-019 Study Group. Prevalence and burden of respiratory syncytial virus in older adults across Europe (2021–2024).
- Centers for Disease Control and Prevention – Respiratory Syncytial Virus (RSV) in Older Adults: Symptoms, Prevention, and Vaccination Guidance.
- World Health Organization – RSV global epidemiology and disease burden reports.
- National Institute of Allergy and Infectious Diseases – Research on respiratory viruses and immune response in aging populations.
Frequently Asked Questions (FAQ)
What is RSV and who does it affect?
RSV is a common respiratory virus that affects people of all ages, but it can be especially serious for infants and older adults.
How long do RSV symptoms last in older adults?
Symptoms can last around three weeks on average, with some people experiencing lingering cough and fatigue even longer.
What are the most common RSV symptoms in seniors?
Common symptoms include cough, shortness of breath, fatigue, and nasal congestion. A productive cough and breathing difficulty are more common compared to other infections.
Why is RSV hard to diagnose?
RSV symptoms are very similar to other respiratory illnesses like the flu or COVID-19, making laboratory testing necessary for accurate diagnosis.
Are antibiotics effective for RSV?
No, RSV is caused by a virus, so antibiotics are not effective. However, they are sometimes prescribed unnecessarily.
Can RSV vaccines help older adults?
Yes, RSV vaccines can help prevent infections and reduce the severity of symptoms, improving overall quality of life.
